Donald Notman | CFO |
Antony Mattessich | President, CEO & Director |
Michael Goldstein | Chief Medical Officer |
Joseph Catanzaro | Piper Sandler & Co. |
Yi Chen | H.C. Wainwright & Co. |
Dane Leone | Raymond James & Associates |
Jonathan Wolleben | JMP Securities |
Good Morning, ladies and gentlemen. Thank you for standing by, and welcome to the Ocular Therapeutix Second Quarter 2020 Earnings Conference Call. [Operator Instructions]. It is now my pleasure to turn the call over to Donald Notman, Chief Financial Officer at Ocular Therapeutix. Please go ahead, sir.